Anthem / Elevance Denied Your Cancer Treatment?
Anthem Blue Cross Blue Shield (Elevance Health) denies 15.3% of claims on average. But 54% of appeals succeed when patients fight back. Your cancer treatment denial may have grounds for a successful appeal.
Why Anthem / Elevance Denies Cancer Treatment
Treatment classified as experimental or investigational
Not following insurer-preferred treatment protocol
Out-of-network oncologist required for specialized care
Anthem / Elevance's Common Denial Tactics
Referencing outdated clinical criteria
Bundling denials across multiple related claims
Claiming services are "not medically necessary" without specific reasoning
How to Win Your Cancer Treatment Appeal
NCCN guidelines supporting the treatment protocol
Peer-reviewed studies and clinical trial results
Oncologist letter with detailed treatment rationale
FDA approval documentation for the specific indication
Consider attorney involvement for high-value cancer treatment denials
Laws That Protect You
ACA — Cancer screening and treatment as Essential Health Benefits
State cancer treatment mandate laws
Clinical trial coverage requirements (ACA §2709)
Tips for Appealing to Anthem / Elevance
Demand the specific clinical policy bulletin used for the denial
Check if your state mandates coverage for the denied service
File an external review — Anthem has a 54% overturn rate on appeal
Ready to Fight Your Cancer Treatment Denial?
Upload your denial letter and get an AI-powered analysis in minutes. We'll identify the weaknesses in Anthem / Elevance's reasoning and build your appeal strategy.
Analyze My Denial FreeAnalysis is always free. No credit card required.
This information is for educational and informational purposes only. It does not constitute legal or medical advice. Statistics cited are from publicly available sources including KFF, HHS OIG, and state insurance department data. Individual results may vary. Consult a qualified professional before taking action on your specific situation.